Cargando…

Umbilical cord blood: A promising source for allogeneic CAR-T cells

Chimeric antigen receptor T (CAR-T) cell therapy is an effective treatment for relapsed and refractory acute lymphoblastic leukemia (R/R ALL). However, autologous CAR-T cells derived from patients with B-ALL often show poor amplification ability, exhaustion, and anergy. To overcome these limitations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dian-Dian, Hong, Wei-Cong, Qiu, Kun-Yin, Li, Xin-Yu, Liu, Yong, Zhu, Li-Wen, Lai, Wei-Xin, Chen, Han-, Yang, Hua-Qing, Xu, Lu-Hong, Fang, Jian-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373021/ https://www.ncbi.nlm.nih.gov/pubmed/35965561 http://dx.doi.org/10.3389/fonc.2022.944248

Ejemplares similares

Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia
por: Li, Xin-Yu, et al.
Publicado: (2022)

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia
por: Pasvolsky, Oren, et al.
Publicado: (2022)

Umbilical cord blood: The promise and the uncertainty
por: Kindwall‐Keller, Tamila L., et al.
Publicado: (2020)

Allogenic umbilical cord tissue for temporomandibular joint injuries
por: Aratikatla, Adarsh, et al.
Publicado: (2023)

Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
por: Caël, Blandine, et al.
Publicado: (2022)

Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant
por: Liu, Pengjiang, et al.
Publicado: (2020)

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia
por: Liu, Jia, et al.
Publicado: (2021)

Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
por: Couto, Samuel C. F., et al.
Publicado: (2023)

Umbilical cord: an allogenic tissue for potential treatment of COVID-19
por: Rodriguez, Hugo C., et al.
Publicado: (2020)

Allogenic Umbilical Cord Tissue as a Scaffold for Ankle Osteoarthritis
por: Gupta, Ashim, et al.
Publicado: (2023)

In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy
por: Xin, Tianqing, et al.
Publicado: (2022)

Umbilical cord blood application analysis of Guangdong Cord Blood Bank
por: Shi, Cong-Ying, et al.
Publicado: (2020)

Umbilical cord blood derived cellular therapy: advances in clinical development
por: Wang, Jiasheng, et al.
Publicado: (2023)

Umbilical cord blood: Current status & promise for the future
por: McKenna, David, et al.
Publicado: (2011)

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
por: Xue, YuanBo, et al.
Publicado: (2021)

Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion
por: Qiu, Ying, et al.
Publicado: (2017)

Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells as a Potential Source for Cartilage and Bone Regeneration: An In Vitro Study
por: Marmotti, A., et al.
Publicado: (2017)

Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
por: Yang, Wan-Zhang, et al.
Publicado: (2010)

An Alternative Source for Allogeneic CAR T Cells With a High Safety Profile
por: Wu, Xiaolong, et al.
Publicado: (2022)

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results
por: Li, Zhihui, et al.
Publicado: (2023)

Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients
por: Lopedote, Paolo, et al.
Publicado: (2023)

Contouring lumbosacral plexus nerves with MR neurography and MR/CT deformable registration technique
por: Cao, Xi, et al.
Publicado: (2022)

Exosomes Derived From MicroRNA-148b-3p-Overexpressing Human Umbilical Cord Mesenchymal Stem Cells Restrain Breast Cancer Progression
por: Yuan, Lei, et al.
Publicado: (2019)

CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future
por: Zhang, Zhengchao, et al.
Publicado: (2022)

Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro
por: Liu, Xiaohuan, et al.
Publicado: (2015)

Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach
por: Zhang, He, et al.
Publicado: (2021)

One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study
por: Lu, Jing, et al.
Publicado: (2021)

Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor
por: Peng, Wei, et al.
Publicado: (2022)

Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
por: Suh, Kangho, et al.
Publicado: (2022)

Infusion of allogeneic umbilical cord blood hematopoietic stem cells in patients with chemotherapy-related myelosuppression
por: YAO, YI, et al.
Publicado: (2014)

Intramuscular Transplantation of Allogeneic Mesenchymal Stromal Cells Derived from Equine Umbilical Cord
por: Dias, Marianne Camargos, et al.
Publicado: (2016)

Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients
por: Wong, Joy, et al.
Publicado: (2023)

Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma
por: Jiang, Wei, et al.
Publicado: (2021)

Umbilical cord blood transplantation
por: Koo, Hong Hoe, et al.
Publicado: (2012)

Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
por: Li, Meng-Yun, et al.
Publicado: (2020)

Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
por: Suh, Kangho, et al.
Publicado: (2022)

Prediction Model for Lung Cancer in High-Risk Nodules Being Considered for Resection: Development and Validation in a Chinese Population
por: Xia, Chunqiu, et al.
Publicado: (2021)

Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
por: Kumar, Jeetendra, et al.
Publicado: (2015)

B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
por: Long, Cheng, et al.
Publicado: (2021)

Comparison of characteristics and outcomes on ETP-ALL/LBL and non-ETP ALL patients receiving allogeneic hematopoietic stem cell transplantation
por: Chen, Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rdi0dc8rfhcaj7gp7tojfsk0ns